Considering that the potential UPF1 targets were enriched mainly in immune-related signaling pathways, we focused on COX-2 and PD-L1, two crucial factors in immunomodulation and tumor progression, as candidate UPF1 targets in NPC. The gene discussed is UPF1; the disease is nasopharyngeal carcinoma.